NEW CLINICAL TRIAL FOR PATIENTS WITH ASBESTOS RELATED LUNG CANCER
The Mesothelioma Center at NewYork-Presbyterian Hospital and Columbia University Medical Center is now recruiting patients for a clinical research study of a new targeted radiation and chemotherapy protocol for pleural mesothelioma.
Dr Robert Taub, who is the director of the New York Mesothelioma Center and professor of Clinical Medicine at Columbia University says:
"Current surgical and chemotherapy treatments of patients with malignant pleural mesothelioma are unsatisfactory, and have not been shown to significantly prolong survival. In this study, we will investigate whether a combination of chemotherapy and radiation targeted directly at the lung's lining can improve outcomes while avoiding surgery." He went on to comment that this approach has shown minimal toxic side effects when compared to systemic chemotherapy.
To find out more, contact the address below:
Office of Public Affairs
NewYork-Presbyterian Hospital/Columbia University Medical Center
627 West 165th Street
New York, NY 10032
tel: 212.305.5587
fax: 212.305.8023
email: pr@nyp.org